ArticleCancer chemotherapy and pharmacology2024

A polo-like kinase 1 inhibitor enhances erastin sensitivity in head and neck squamous cell carcinoma cells in vitro.

Xiangping Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.